Market accessOfficial

AIFA issues sunset clause pre-notice for products at risk of lapsing in early 2027

🇮🇹 AIFA · Tue 17 Nov 2026

Italy's medicines agency has published a warning listing products that could lose authorisation for non-marketing, with lapse dates falling between 1 January and 31 March 2027.

The Italian Medicines Agency (AIFA) published on 17 November 2026 a pre-notice of lapse under the sunset clause. The attached communication lists medicinal products that are potentially at risk of losing their authorisation because they have not been marketed.

Subscribe to keep reading

$4.99 / month

  • Every article, analysis and opinion piece on VigiEye and CompePharma
  • One subscription for both sites, cancel any time
Continue with Google
or
You'll be signed in straight away; we also email you a link to confirm your address. Reading every article takes a $4.99/month subscription (secure checkout by Stripe), billed monthly until you cancel; access starts at once, so the 14-day withdrawal right ends when it does. See our terms and privacy policy.

Official source: AIFA ↗

Article written by VigiEye from the official source (AIFA). AI-assisted; check the source before acting.